Because previous studies implicated elevated G6PD activity in prostate adenocarcinomas compared with normal or benign prostatic hyperplasia tissues,25, 26 and G6PD overexpression is observed in several types of cancers,21, 22, 23 we focused primarily on this rate-limiting enzyme. The gene discussed is G6PD; the disease is benign prostatic hyperplasia.